0001209191-17-063045.txt : 20171130 0001209191-17-063045.hdr.sgml : 20171130 20171130170425 ACCESSION NUMBER: 0001209191-17-063045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171129 FILED AS OF DATE: 20171130 DATE AS OF CHANGE: 20171130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHONEY DAVID L CENTRAL INDEX KEY: 0001224091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 171231812 MAIL ADDRESS: STREET 1: SYMANTEC CORPORATION STREET 2: 20330 STEVENS CREEK BLVD. CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-29 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001224091 MAHONEY DAVID L C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 1 0 0 0 Stock Option (Right to Buy) 35.12 2017-11-29 4 A 0 10000 0.00 A 2027-11-28 Common Stock 10000 10000 D The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from November 29, 2017, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date. /s/ Jennifer Rhodes, Attorney-in-fact 2017-11-30